Straits Times Index
3,209.04 +29.46 (+0.93%) Nikkei
26,604.84 -72.96 (-0.27%) Hang Seng
20,051.45 -119.82 (-0.59%) FTSE 100
7,524.30 +1.55 (+0.02%) BTC-USD
29,647.79 -97.81 (-0.33%) CMC Crypto 200
654.32 -16.69 (-2.49%)
Amyris, Inc. (AMRS)
After hours:
| Previous close | 2.1800 |
| Open | 2.1850 |
| Bid | 0.0000 x 4000 |
| Ask | 0.0000 x 21500 |
| Day's range | 1.9800 - 2.2200 |
| 52-week range | 1.4700 - 17.4200 |
| Volume | |
| Avg. volume | 5,987,177 |
| Market cap | 677.794M |
| Beta (5Y monthly) | 1.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Better Buy: Gingko Bioworks vs. Amyris
Not long ago, Amyris and Gingko Bioworks were stock-market darlings, but the rout in tech stocks this year has been especially tough on these two. Shares of this synthetic biology start-up shot higher following its stock-market debut last year. The good times didn't last long, though, and now Gingko Bioworks stock is down more than 80% from its all-time high.
- Zacks
Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1
Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.
- Motley Fool
Amyris (AMRS) Q1 2022 Earnings Call Transcript
This call is being webcast live on the events page of the investors' section of Amyris website at amyris.com. You may listen to a webcast replay of this call by going to the investors' section of Amyris website. With me on today's call is John Melo, president and chief executive officer.
